Jenni Griffith, PA
Physician Assistant · Casper, WYNPI 1952881872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $602 and has fallen 51.2% since, to $294 in 2025. Among physician assistant clinicians in WY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$314
- Dendreon Pharmaceuticals LLC$310
- Johnson & Johnson$239
- Pfizer$217
- Merck$157
- Astellas Pharma US Inc$145
- plus $832 from 17 others
What the payments were for
- Food & beverage$2,10995%
- Education$1045%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $314 |
| Dendreon Pharmaceuticals LLC | 19 | $310 |
| Johnson & Johnson | 10 | $239 |
| Pfizer | 11 | $217 |
| Merck | 7 | $157 |
| Astellas Pharma US Inc | 8 | $145 |
| AbbVie(2 entities) | 7 | $131 |
| Myovant Sciences Inc. | 5 | $98 |
| Coloplast | 5 | $83 |
| 180 Medical, Inc. | 4 | $83 |
| Bayer | 4 | $82 |
| Endo Pharmaceuticals Inc. | 3 | $60 |
| Laborie Medical Technologies Corp. | 1 | $50 |
| Axonics, Inc. | 1 | $42 |
| Accord Healthcare, Inc. | 2 | $36 |
| Procept Biorobotics Corporation | 1 | $27 |
| Abbott | 1 | $25 |
| Rochester Medical Corporation | 1 | $25 |
| Tolmar, Inc. | 1 | $24 |
| Palette Life Sciences, Inc. | 1 | $23 |
| Urogen Pharma, Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
| Profound Medical Corp. | 1 | $12 |
How this compares
$2,213 in reported general payments places this provider in the 90th percentile of 203 physician assistant providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 62 | $48,794 |
| ElmironPentosan Polysulfate Sodium | 12 | $12,916 |
| Tamsulosin Hcl | 494 | $10,848 |
| GemtesaVibegron | 15 | $8,915 |
| Oxybutynin Chloride ErOxybutynin Chloride | 209 | $5,745 |
| Finasteride | 219 | $3,727 |
| Solifenacin Succinate | 88 | $3,521 |
| Trospium Chloride | 56 | $2,957 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 21 | $2,376 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 54 | $2,231 |
| Trimethoprim | 39 | $1,947 |
| Testosterone Cypionate | 30 | $1,395 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $1,194 |
| Doxazosin Mesylate | 70 | $916 |
| NitrofurantoinNitrofurantoin Macrocrystal | 27 | $836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $145 | $48,79462 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $314 | $8,91515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 203 physician assistant providers in Wyoming.
Other physician assistant in Casper
- Joann RamseyCasper$5K
- Laurie JohnsonCasper$4K
- Robyn MorrisonCasper$4K
- Lacey MartinCasper$3K
- Chad SundquistCasper$3K
- Gordon EricksonCasper$2K
- Sarah HallCasper$2K
- Kelli ClairCasper$2K
- Devin TracyCasper$1K
- McKenna SpillarCasper$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.